Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience

J Gastrointestin Liver Dis. 2008 Jun;17(2):187-91.
No abstract available

Publication types

  • Review

MeSH terms

  • Biomarkers / blood*
  • Diagnosis, Differential
  • Fatty Liver / blood*
  • Fatty Liver / complications
  • Fatty Liver / diagnosis
  • Hepatitis / blood*
  • Hepatitis / complications
  • Hepatitis / diagnosis
  • Humans
  • Liver Cirrhosis / blood*
  • Liver Cirrhosis / complications
  • Liver Cirrhosis / diagnosis
  • Mass Screening / methods*
  • Metabolic Syndrome / blood
  • Metabolic Syndrome / complications*
  • Risk Factors

Substances

  • Biomarkers